The Impact of Symptom Management Nursing Intervention on the QoL of Patients With Advanced Lung C… (NCT07679165) | Clinical Trial Compass
CompletedNot Applicable
The Impact of Symptom Management Nursing Intervention on the QoL of Patients With Advanced Lung Cancer: Mediation of Self-management Efficacy and Regulation of Psychological Resilience
China176 participantsStarted 2023-06-10
Plain-language summary
Symptom management nursing intervention can improve the self-management efficacy, psychological resilience, and QoL of patients with advanced lung cancer.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* According to the diagnostic criteria of primary lung cancer \[9\], the clinical stage was stage ⅢB-Ⅳ
* aged 18-75 years old
* Karnofsky performance status (KPS) ≥60 and expected survival ≥3 months
* Patients had clear consciousness and normal cognitive function, and could complete the questionnaire independently or with the assistance of the researcher
* have basic communication skills and can cooperate to complete the whole intervention
* Patients or their families informed and signed the consent form.
Exclusion Criteria:
* primary malignant tumors in other parts
* history of severe heart, liver, kidney and other important organ failure, severe infection or mental illness
* Unable to cooperate with the study due to cognitive impairment, visual and hearing impairment
* participating in other similar nursing intervention studies.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Quality of Life as measured by the Functional Assessment of Cancer Therapy-Lung (FACT-L) Scale
Timeframe: Baseline (within 24 hours of admission) and at 8 weeks (immediately post-intervention)